Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment.

Salazar de Pablo G, Catalan A, Fusar-Poli P

Open source

DOI
10.1001/jamapsychiatry.2019.3561
Published
2020 Mar 1
Container
JAMA psychiatry
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamapsychiatry.2019.3561,
  title = {Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment.},
  author = {Salazar de Pablo G and Catalan A and Fusar-Poli P},
  year = {2020},
  journal = {JAMA psychiatry},
  doi = {10.1001/jamapsychiatry.2019.3561},
  url = {https://doi.org/10.1001/jamapsychiatry.2019.3561}
}

RIS

TY  - JOUR
TI  - Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment.
AU  - Salazar de Pablo G
AU  - Catalan A
AU  - Fusar-Poli P
PY  - 2020
JO  - JAMA psychiatry
DO  - 10.1001/jamapsychiatry.2019.3561
UR  - https://doi.org/10.1001/jamapsychiatry.2019.3561
ER  - 

APA

G, S. D. P., A, C., & P, F. (2020). Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment.. JAMA psychiatry. https://doi.org/10.1001/jamapsychiatry.2019.3561

Source records